Skip to main content
Top
Published in: Sleep and Breathing 1/2024

10-08-2023 | Trisomy 21 | Sleep Breathing Physiology and Disorders • Original Article

Prevalence, associated risk factors, and respiratory event distribution of obstructive sleep apnea in children with Down syndrome

Authors: Egambaram Senthilvel, Kahir Jawad, Bakeerathan Gunaratnam, Juhee N. Mian, Karim El-Kersh

Published in: Sleep and Breathing | Issue 1/2024

Login to get access

Abstract

Purpose

Children with Down Syndrome (DS) have a high prevalence of obstructive sleep apnea (OSA). We aimed to assess OSA prevalence in a single center cohort of children with DS, identify associated risk factors of obstructive respiratory events, and examine the influence of different sleep stages and body positions on respiratory events distribution.

Methods

Single center retrospective study that included children with DS who underwent overnight polysomnogram (PSG). OSA severity was categorized by obstructive apnea–hypopnea index (OAHI) as mild (1.5–4.9 events/h), moderate (5–9.9 events/h), and severe (≥ 10 events/h). A logistic regression analysis was used to examine the association between OSA-related risk factors in normal and abnormal OAHI category and in REM and Non-REM predominant AHI groups.

Results

PSG data were available for 192 children with a median age of 5 years (IQR 7). OSA prevalence was 82.3% (27.1% mild, 19.8% moderate, and 35.4% severe). A logistic regression model identified BMI and being an African American as significant predictors for OAHI severity. In children with OSA, the median OAHI was 7.6 and obstructive respiratory events were more common in REM sleep and in the supine position. The median REM OAHI was 20 events/h (IQR: 24.4), whereas the median Non-REM OAHI was 5.2 events/h (IQR: 12.6 p < 0.0001). Similarly, supine OAHI was 11.6 (IQR: 19.3) and off supine OAHI was 6.6 (IQR: 11.6, p = 0.0004). Age was a significant predictor (p = 0.012) for Non-REM predominant OSA which was present in 15.2% of children with OSA.

Conclusion

Children with DS have a high prevalence of OSA. Higher BMI and being an African American were significant associated risk factors for higher OAHI. Obstructive respiratory events in children with DS occur predominantly in REM sleep and in the supine position. Non-REM predominant distribution of respiratory events was noted in older children with DS.
Literature
2.
26.
go back to reference Iber C, Ancoli-Israel S, Chesson AL, Quan SF (2017) The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. vol 1. American academy of sleep medicine Westchester, IL Iber C, Ancoli-Israel S, Chesson AL, Quan SF (2017) The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. vol 1. American academy of sleep medicine Westchester, IL
28.
go back to reference Marcus CL, Keens TG, Bautista DB, von Pechmann WS, Ward SL (1991) Obstructive sleep apnea in children with Down syndrome. Pediatrics 88(1):132–139CrossRefPubMed Marcus CL, Keens TG, Bautista DB, von Pechmann WS, Ward SL (1991) Obstructive sleep apnea in children with Down syndrome. Pediatrics 88(1):132–139CrossRefPubMed
30.
go back to reference Styles M, Cole T, Dennis J, Preece M (2002) New cross sectional stature, weight, and head circumference references for Down’s syndrome in the UK and Republic of Ireland. Arch Dis Child 87(2):104–108CrossRefPubMedPubMedCentral Styles M, Cole T, Dennis J, Preece M (2002) New cross sectional stature, weight, and head circumference references for Down’s syndrome in the UK and Republic of Ireland. Arch Dis Child 87(2):104–108CrossRefPubMedPubMedCentral
34.
go back to reference da Rocha M, Ferraz RCM, Chen VG, Moreira GA, Fujita RR (2017) Clinical variables determining the success of adenotonsillectomy in children with Down syndrome. Int J Pediatr Otorhinolaryngol 102:148–153CrossRefPubMed da Rocha M, Ferraz RCM, Chen VG, Moreira GA, Fujita RR (2017) Clinical variables determining the success of adenotonsillectomy in children with Down syndrome. Int J Pediatr Otorhinolaryngol 102:148–153CrossRefPubMed
35.
go back to reference Attal P, Chanson P (2010) Endocrine aspects of obstructive sleep apnea. J Clin Endocrinol Metab 95(2):483–495CrossRefPubMed Attal P, Chanson P (2010) Endocrine aspects of obstructive sleep apnea. J Clin Endocrinol Metab 95(2):483–495CrossRefPubMed
36.
39.
go back to reference Santoro JD, Del Rosario J, Osterbauer B, Gillett ES, Don DM (2021) Sleep positions in children with Down syndrome and obstructive sleep apnea. Sleep Med 81:463–465CrossRefPubMed Santoro JD, Del Rosario J, Osterbauer B, Gillett ES, Don DM (2021) Sleep positions in children with Down syndrome and obstructive sleep apnea. Sleep Med 81:463–465CrossRefPubMed
Metadata
Title
Prevalence, associated risk factors, and respiratory event distribution of obstructive sleep apnea in children with Down syndrome
Authors
Egambaram Senthilvel
Kahir Jawad
Bakeerathan Gunaratnam
Juhee N. Mian
Karim El-Kersh
Publication date
10-08-2023
Publisher
Springer International Publishing
Published in
Sleep and Breathing / Issue 1/2024
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-023-02900-6

Other articles of this Issue 1/2024

Sleep and Breathing 1/2024 Go to the issue

Sleep Breathing Physiology and Disorders • Review

Influence of nutrition and food on sleep—is there evidence?

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine